BACKGROUND: Accumulating data show a causal role for flavanols in the mediation of cardiovascular benefits associated with the consumption of flavanol- and procyanidin-containing foods. Evidence for a direct causal role for procyanidins in this context is far less profound due to the poor absorption of procyanidins. However, it has been proposed that procyanidins may break down in the gastrointestinal tract, resulting in monomeric flavanols, which contribute to the systemic flavanol pool. Verification or rejection of this supposition could significantly affect the interpretation of epidemiologic and dietary intervention data and the design of food-content databases. OBJECTIVE: We assessed the respective contribution of flavanols and procyanidins to the systemic pool of flavanols and 5-(3,4-dihydroxyphenyl)-γ-valerolactone (γ-VL) in humans. DESIGN: Test drinks that contained only flavanols (D1), procyanidins with a degree of polymerization that ranged from 2 to 10 (D2-10), or flavanols and procyanidins with a degree of polymerization that ranged from 2 to 10 (D1-10) were consumed by subjects (n = 12) according to a randomized, double-masked, crossover design. Plasma and urine samples were collected postprandially and analyzed. RESULTS: The ingestion of D1-10 resulted in the systemic presence of flavanols (plasma concentration: 863 ± 77 nmol/L), γ-VLs (24-h urine: 93 ± 18 μmol), and minute concentrations of procyanidin B2. With correction for small residual amounts of flavanols present in D2-10, only negligible concentrations of circulating flavanols were detected after ingestion of the drink, whereas the intake of D1 resulted in circulating flavanol concentrations similar to those detected after D1-10 consumption. CONCLUSIONS: These outcomes show that dietary procyanidins do not contribute to the systemic pool of flavanols in humans. Thus, these data reject the notion that procyanidins, through their breakdown into flavanols and subsequent absorption, causally modulate vascular function.
RCT Entities:
BACKGROUND: Accumulating data show a causal role for flavanols in the mediation of cardiovascular benefits associated with the consumption of flavanol- and procyanidin-containing foods. Evidence for a direct causal role for procyanidins in this context is far less profound due to the poor absorption of procyanidins. However, it has been proposed that procyanidins may break down in the gastrointestinal tract, resulting in monomeric flavanols, which contribute to the systemic flavanol pool. Verification or rejection of this supposition could significantly affect the interpretation of epidemiologic and dietary intervention data and the design of food-content databases. OBJECTIVE: We assessed the respective contribution of flavanols and procyanidins to the systemic pool of flavanols and 5-(3,4-dihydroxyphenyl)-γ-valerolactone (γ-VL) in humans. DESIGN: Test drinks that contained only flavanols (D1), procyanidins with a degree of polymerization that ranged from 2 to 10 (D2-10), or flavanols and procyanidins with a degree of polymerization that ranged from 2 to 10 (D1-10) were consumed by subjects (n = 12) according to a randomized, double-masked, crossover design. Plasma and urine samples were collected postprandially and analyzed. RESULTS: The ingestion of D1-10 resulted in the systemic presence of flavanols (plasma concentration: 863 ± 77 nmol/L), γ-VLs (24-h urine: 93 ± 18 μmol), and minute concentrations of procyanidin B2. With correction for small residual amounts of flavanols present in D2-10, only negligible concentrations of circulating flavanols were detected after ingestion of the drink, whereas the intake of D1 resulted in circulating flavanol concentrations similar to those detected after D1-10 consumption. CONCLUSIONS: These outcomes show that dietary procyanidins do not contribute to the systemic pool of flavanols in humans. Thus, these data reject the notion that procyanidins, through their breakdown into flavanols and subsequent absorption, causally modulate vascular function.
Authors: Joseph F Pierre; Aaron F Heneghan; Rodrigo P Feliciano; Dhanansayan Shanmuganayagam; Christian G Krueger; Jess D Reed; Kenneth A Kudsk Journal: JPEN J Parenter Enteral Nutr Date: 2013-01-28 Impact factor: 4.016
Authors: Israel Ramirez-Sanchez; Pam R Taub; Theodore P Ciaraldi; Leonardo Nogueira; Taylor Coe; Guy Perkins; Michael Hogan; Alan S Maisel; Robert R Henry; Guillermo Ceballos; Francisco Villarreal Journal: Int J Cardiol Date: 2013-07-17 Impact factor: 4.164
Authors: Anna Vogiatzoglou; Angela A Mulligan; Amit Bhaniani; Marleen A H Lentjes; Alison McTaggart; Robert N Luben; Christian Heiss; Malte Kelm; Marc W Merx; Jeremy P E Spencer; Hagen Schroeter; Kay-Tee Khaw; Gunter G C Kuhnle Journal: Free Radic Biol Med Date: 2015-03-17 Impact factor: 7.376
Authors: Gianni Belcaro; Andrea Ledda; Shu Hu; Maria Rosa Cesarone; Beatrice Feragalli; Mark Dugall Journal: Evid Based Complement Alternat Med Date: 2013-09-19 Impact factor: 2.629
Authors: Javier I Ottaviani; Gina Borges; Tony Y Momma; Jeremy P E Spencer; Carl L Keen; Alan Crozier; Hagen Schroeter Journal: Sci Rep Date: 2016-07-01 Impact factor: 4.379